Pro-inflammatory cytokines and chemokines are increased in COVID-19, one of the reasons being the activation of the NF-κB and STAT3 pathways, leading to the activation of IL-6, which results in the release of pro-inflammatory cytokines and chemokines, activated T-cells, and activated B-cells. The gene discussed is IL6; the disease is COVID-19.